KLAS Report Cites Alaris® System As Leader In Interoperability With EMRs

CareFusion Has Most Organizations Live and Leads in Breadth of Functionality

Jun 9, 2015

SAN DIEGO,CA, June 9, 2015 /PRNewswire/ - CareFusion, a BD company (NYSE:BDX), today announced its Alaris® System intelligent infusion platform has been rated as the smart pump industry leader for interoperability with electronic medical records (EMRs) in the Smart Pump/EMR Integration report released today from KLAS.

The report from KLAS, an organization that independently monitors health care information technology performance through the active participation of thousands of health care organizations, says the Alaris System has the most organizations live with EMR interoperability solutions and cited CareFusion as leading in breadth of interoperability functionality.

"CareFusion has surpassed all other pump vendors to have the most organizations live with integration, having added seven since the last report," the KLAS report states. "They are also the only vendor live with syringe pump integration, and their customers are the most confident that pump integration is ready for widespread adoption."

The Alaris System can be wirelessly pre-populated with infusion order parameters directly from a hospital's EMR. Instead of manually programming the pump using the keypad, the pump is pre-populated with the patient's medication order after scanning the barcodes on the patient's ID band, on the medication to be administered and on the Alaris System smart infusion pump. Wirelessly programming the Alaris System with the patient's medication order from the verified physician order in the EMR helps ensure accurate IV medication administration and documentation, and reduces opportunities for human error.

With bi-directional communication, infusion data automatically flows back into the EMR, resulting in the programmed infusion order parameters being sent back into the patient's medical record in near real-time.1 Automated IV medication administration documentation from the Alaris System to the EMR gives health care providers more timely and accurate infusion data to aid in clinical decision-making.

About BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.

For more information on BD, please visit bd.com.

Matthew Coppola

201 847 7370

Back to News Releases

1Subject to Internet connection, device variability and selected settings.

This site uses cookies. If you click accept cookies then all cookies will be written. Please review our cookies policy and configure your cookies for your experience.